DE602005016659D1 - Wässrige zusammensetzung mit einem thiazol-derivat - Google Patents
Wässrige zusammensetzung mit einem thiazol-derivatInfo
- Publication number
- DE602005016659D1 DE602005016659D1 DE602005016659T DE602005016659T DE602005016659D1 DE 602005016659 D1 DE602005016659 D1 DE 602005016659D1 DE 602005016659 T DE602005016659 T DE 602005016659T DE 602005016659 T DE602005016659 T DE 602005016659T DE 602005016659 D1 DE602005016659 D1 DE 602005016659D1
- Authority
- DE
- Germany
- Prior art keywords
- aqueous composition
- thiazole derivative
- sup
- sugar
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US55395604P | 2004-03-18 | 2004-03-18 | |
PCT/JP2005/005607 WO2005089755A1 (en) | 2004-03-18 | 2005-03-18 | Aqueous composition comprising thiazole derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602005016659D1 true DE602005016659D1 (de) | 2009-10-29 |
Family
ID=34961865
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602005016659T Active DE602005016659D1 (de) | 2004-03-18 | 2005-03-18 | Wässrige zusammensetzung mit einem thiazol-derivat |
Country Status (11)
Country | Link |
---|---|
US (1) | US20070208068A1 (de) |
EP (1) | EP1737450B1 (de) |
JP (2) | JP4881159B2 (de) |
KR (1) | KR101206319B1 (de) |
CN (1) | CN1933833B (de) |
AT (1) | ATE442849T1 (de) |
CA (1) | CA2558135C (de) |
DE (1) | DE602005016659D1 (de) |
ES (1) | ES2331890T3 (de) |
TW (1) | TWI339659B (de) |
WO (1) | WO2005089755A1 (de) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040033228A1 (en) | 2002-08-16 | 2004-02-19 | Hans-Juergen Krause | Formulation of human antibodies for treating TNF-alpha associated disorders |
KR20070050932A (ko) * | 2004-07-27 | 2007-05-16 | 가부시키가이샤 아루떼꾸 우에노 | Vap―1 억제 활성을 가지는 티아졸 유도체 |
TW200835687A (en) * | 2006-11-30 | 2008-09-01 | R Tech Ueno Ltd | Thiazole derivatives and their use as VAP-1 inhibitor |
CN103120690A (zh) * | 2007-10-19 | 2013-05-29 | 株式会社·R-技术上野 | 用于治疗白内障的药物组合物 |
TWI437986B (zh) * | 2008-01-31 | 2014-05-21 | R Tech Ueno Ltd | 噻唑衍生物及使用該衍生物作為vap-1抑制劑之用途 |
UA112154C2 (uk) | 2009-09-08 | 2016-08-10 | Біоті Терапіс Корп. | Застосування повністю людського анти-vap-1-антитіла для лікування фіброзних станів |
US9079891B2 (en) * | 2010-08-27 | 2015-07-14 | Calcimedica, Inc. | Compounds that modulate intracellular calcium |
US20160113893A1 (en) | 2013-06-12 | 2016-04-28 | Proximagen Limited | New therapeutic uses of enzyme inhibitors |
JP6483148B2 (ja) | 2014-03-14 | 2019-03-13 | エアーピオ セラピューティクス インコーポレイテッド | HPTP−β阻害剤 |
WO2015189534A1 (en) | 2014-06-12 | 2015-12-17 | Proximagen Limited | Vap-1 inhibitors for treating muscular dystrophy |
EP3233762A1 (de) * | 2014-12-18 | 2017-10-25 | Basaran, Mustafa | Organisches und anorganisches düngemittel für bewässerungslandwirtschaft und mit nitrifikationshemmendem mittel und bor |
EP3386494A1 (de) | 2015-12-07 | 2018-10-17 | Benevolentai Cambridge Limited | Vap-1-inhibitoren zur schmerzbehandlung |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0696533B2 (ja) * | 1987-01-14 | 1994-11-30 | 北陸製薬株式会社 | キノロンカルボン酸の水性組成物 |
CA2125060C (en) * | 1993-07-02 | 1999-03-30 | Henry P. Dabrowski | Ophthalmic solution for artificial tears |
ATE236890T1 (de) * | 1996-12-23 | 2003-04-15 | Bristol Myers Squibb Pharma Co | Sauerstoff oder schwefel enthaltende 5-gliedrige heteroaromatishe derivative als factor xa hemmer |
AR002194A1 (es) * | 1997-03-17 | 1998-01-07 | Sanchez Reynaldo Alemany | Instrumento computarizado para el analisis del movimiento. |
CN1229110C (zh) * | 1997-07-29 | 2005-11-30 | 阿尔康实验室公司 | 含半乳甘露聚糖聚合物和硼酸盐的眼用组合物 |
CA2407587A1 (en) * | 2000-04-28 | 2001-11-08 | Sankyo Company, Limited | Ppar.gamma. modulators |
JP2002179572A (ja) * | 2000-10-06 | 2002-06-26 | Nikken Chem Co Ltd | アレルギー性眼疾患治療剤 |
CN100491361C (zh) * | 2003-01-27 | 2009-05-27 | 安斯泰来制药有限公司 | 噻唑衍生物及其作为vap-1抑制剂的用途 |
CA2514573A1 (en) * | 2003-01-27 | 2004-08-12 | Astellas Pharma Inc. | Thiazole derivatives and their use as vap-1 inhibitors |
US20060229346A1 (en) * | 2003-03-31 | 2006-10-12 | Sucampo Ag | Method for treating vascular hyperpermeable disease |
-
2005
- 2005-03-18 JP JP2006529411A patent/JP4881159B2/ja not_active Expired - Fee Related
- 2005-03-18 KR KR1020067019065A patent/KR101206319B1/ko not_active IP Right Cessation
- 2005-03-18 TW TW094108308A patent/TWI339659B/zh not_active IP Right Cessation
- 2005-03-18 US US10/591,986 patent/US20070208068A1/en not_active Abandoned
- 2005-03-18 EP EP05721534A patent/EP1737450B1/de not_active Not-in-force
- 2005-03-18 DE DE602005016659T patent/DE602005016659D1/de active Active
- 2005-03-18 AT AT05721534T patent/ATE442849T1/de not_active IP Right Cessation
- 2005-03-18 CA CA2558135A patent/CA2558135C/en not_active Expired - Fee Related
- 2005-03-18 CN CN2005800084472A patent/CN1933833B/zh not_active Expired - Fee Related
- 2005-03-18 ES ES05721534T patent/ES2331890T3/es active Active
- 2005-03-18 WO PCT/JP2005/005607 patent/WO2005089755A1/en active Application Filing
-
2011
- 2011-09-06 JP JP2011194023A patent/JP2012001555A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
ES2331890T3 (es) | 2010-01-19 |
CN1933833A (zh) | 2007-03-21 |
EP1737450A1 (de) | 2007-01-03 |
EP1737450B1 (de) | 2009-09-16 |
TW200531967A (en) | 2005-10-01 |
ATE442849T1 (de) | 2009-10-15 |
CA2558135C (en) | 2012-08-14 |
JP2012001555A (ja) | 2012-01-05 |
JP4881159B2 (ja) | 2012-02-22 |
KR20060128011A (ko) | 2006-12-13 |
JP2007529413A (ja) | 2007-10-25 |
CA2558135A1 (en) | 2005-09-29 |
US20070208068A1 (en) | 2007-09-06 |
KR101206319B1 (ko) | 2012-11-29 |
TWI339659B (en) | 2011-04-01 |
WO2005089755A1 (en) | 2005-09-29 |
CN1933833B (zh) | 2011-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE602005016659D1 (de) | Wässrige zusammensetzung mit einem thiazol-derivat | |
GB0418900D0 (en) | Novel salt forms | |
MY157871A (en) | Mapk/erk kinase inhibitors | |
RS53638B1 (en) | CRYSTAL SOLVATES OF DERIVATIVES (1S) -1,5-ANHYDRO-1-C- (3 - ((PHENYL) METHYL) PHENYL) -D-GLUCITOL WITH ALCOHOLS AS INHIBITORS OF SGLT2 FOR TREATMENT OF DIABETES | |
MY140841A (en) | Indozolone derivatives as 11b-hsd1 inhibitors | |
WO2008081096A3 (fr) | Derives quinolinyliques, leur procede de preparation. les compositions pharmaceutiques qui les contiennent et leur utilisation comme agents hypoglycemiants et hypoli pemiants | |
RS53503B1 (en) | AMORPHIC AND CRYSTAL FORM GENZ 112638 HEMITARTARATE AS A GLYCOSILKERAMIDE SYNTHASIS INHIBITOR | |
NO20065719L (no) | I det vesentlige rene 2-{[2-(2-metylamino-pyrimidin-4-yl)-1H-indol-5-karbonyl]-amlno}-3-(fenylpyridin-2-yl-amino)-propionsyre som en IkB kinaseinhibitor. | |
WO2008006044A3 (en) | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method | |
WO2009025239A1 (ja) | 新規外用剤 | |
DK1753723T3 (da) | Substituerede quinolinderivater som mitotiske kinesininhibitorer | |
WO2004096134A3 (en) | Substituted 1,4-diazepines and uses thereof | |
ECSP099073A (es) | Nuevos derivados de piridazina | |
AR061134A1 (es) | Derivados de tioxantina | |
WO2004020430A3 (fr) | Derives de dioxane-2-alkylcarbamates, leur preparation et leur application en therapeutique | |
MY146042A (en) | Water-soluble benzoazepine compound and its pharmaceutical composition | |
GEP20115166B (en) | 2-ARYLINDOLE DERIVATIVES AS mPGES-I INHIBITORS | |
EA200600878A1 (ru) | Производные феноксиуксусных кислот, применимые в качестве двойных агонистов активируемого пероксисомным пролифератором рецептора ( ppar ) | |
CO6331306A2 (es) | Derivados de n-heterociclico-imidazo[1,2alfa]piridina-2-carboxamidas su preparacion y su aplicacion en terapeutica | |
WO2002004598A3 (en) | Improvement of cell culture performance by inhibitors of pyruvate dehydrogenase kinase | |
UY29744A1 (es) | Derivados de 5-piridinil-1-azabiciclo(3.2.1) octano, su preparación y su aplicación en terapeutica. | |
RS54001B1 (en) | SUBSTITUTED [(5H-Pyrrolo [2,1-C] [1,4] BENZODIAZEPIN-11-IL-) PIPERAZIN-1-IL] -2,2-DIMETHYLPROPANOIC ACID COMPOUNDS HT 2A | |
EA201101175A1 (ru) | Фармацевтические комбинации 5-фторурацила и производных 1,4-дигидропиридина и их применение для лечения рака | |
WO2010067010A3 (fr) | Derives de morphine-6-glucuronide, leur preparation et leur application en therapeutique | |
FR2835834B1 (fr) | Nouveaux derives de tricyclo-imidazolines, leur procede de preparation et leur utilisation a titre de medicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
R082 | Change of representative |
Ref document number: 1737450 Country of ref document: EP Representative=s name: PATENT- UND RECHTSANWAELTE KRAUS & WEISERT, 80539 |